25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Macrogen Inc
Buy, Hold or Sell?

Let's analyze Macrogen together

I guess you are interested in Macrogen Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Macrogen Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Macrogen Inc

I send you an email if I find something interesting about Macrogen Inc.

1. Quick Overview

1.1. Quick analysis of Macrogen (30 sec.)










1.2. What can you expect buying and holding a share of Macrogen? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
27.5%

What is your share worth?

Current worth
₩15,094.51
Expected worth in 1 year
₩12,766.07
How sure are you?
52.5%

+ What do you gain per year?

Total Gains per Share
₩-2,328.44
Return On Investment
-13.8%

For what price can you sell your share?

Current Price per Share
₩16,890.00
Expected price per share
₩14,700 - ₩18,750
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Macrogen (5 min.)




Live pricePrice per Share (EOD)
₩16,890.00

2.2. Growth of Macrogen (5 min.)




Is Macrogen growing?

Current yearPrevious yearGrowGrow %
How rich?$105.8m$127.9m-$15.3m-13.6%

How much money is Macrogen making?

Current yearPrevious yearGrowGrow %
Making money-$3.5m-$3.2m-$313.5k-8.7%
Net Profit Margin-14.7%-12.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Macrogen (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Macrogen?

Welcome investor! Macrogen's management wants to use your money to grow the business. In return you get a share of Macrogen.

First you should know what it really means to hold a share of Macrogen. And how you can make/lose money.

Speculation

The Price per Share of Macrogen is ₩16,890. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Macrogen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Macrogen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩15,094.51. Based on the TTM, the Book Value Change Per Share is ₩-582.11 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-535.78 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Macrogen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.200.0%-0.360.0%-0.330.0%-0.240.0%-0.040.0%
Usd Book Value Change Per Share-0.310.0%-0.410.0%-0.380.0%0.070.0%0.150.0%
Usd Dividend Per Share0.000.0%0.000.0%0.100.0%0.110.0%0.060.0%
Usd Total Gains Per Share-0.310.0%-0.410.0%-0.270.0%0.190.0%0.210.0%
Usd Price Per Share12.99-14.12-14.50-18.38-21.55-
Price to Earnings Ratio-16.15--17.48-9.84-29.97-76.89-
Price-to-Total Gains Ratio-42.43-19.66--56.22--277.68--750.48-
Price to Book Ratio1.23-1.26-1.15-1.70-2.92-
Price-to-Total Gains Ratio-42.43-19.66--56.22--277.68--750.48-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.823
Number of shares84
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.11
Usd Book Value Change Per Share-0.410.07
Usd Total Gains Per Share-0.410.19
Gains per Quarter (84 shares)-34.2315.71
Gains per Year (84 shares)-136.9162.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-137-147382553
20-274-2847650116
30-411-42111475179
40-548-558152100242
50-685-695190125305
60-821-832227150368
70-958-969265175431
80-1095-1106303199494
90-1232-1243341224557
100-1369-1380379249620

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%5.07.00.041.7%5.015.00.025.0%21.017.02.052.5%27.017.02.058.7%
Book Value Change Per Share1.03.00.025.0%5.07.00.041.7%7.013.00.035.0%20.020.00.050.0%26.020.00.056.5%
Dividend per Share0.00.04.00.0%6.00.06.050.0%11.00.09.055.0%11.00.029.027.5%11.00.035.023.9%
Total Gains per Share1.03.00.025.0%5.07.00.041.7%8.012.00.040.0%21.019.00.052.5%27.019.00.058.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Macrogen Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---437.157-582.110+33%-535.785+23%106.020-512%218.064-300%
Book Value Per Share--15094.51016053.815-6%18187.961-17%16511.224-9%12792.994+18%
Current Ratio--0.8041.146-30%1.511-47%1.443-44%1.264-36%
Debt To Asset Ratio--0.4380.389+13%0.351+25%0.383+15%0.394+11%
Debt To Equity Ratio--0.7890.650+21%0.543+45%0.654+21%0.684+15%
Dividend Per Share----0%147.076-100%161.173-100%80.586-100%
Enterprise Value--67842154000.00099585741840.000-32%149639887997.500-55%205283049660.500-67%249283265795.008-73%
Eps---287.093-511.001+78%-465.775+62%-343.563+20%-58.205-80%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--0.5620.757-26%1.110-49%1.661-66%2.534-78%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.950+5%
Market Cap169259757000.000-10%185895115000.000202179727500.000-8%208104088500.000-11%263426560450.000-29%309458539072.259-40%
Net Profit Margin---0.095-0.147+55%-0.126+32%0.125-176%0.107-189%
Operating Margin----0%0.001-100%0.017-100%0.013-100%
Operating Ratio--1.2671.534-17%1.378-8%0.999+27%1.012+25%
Pb Ratio1.119-10%1.2291.262-3%1.146+7%1.698-28%2.918-58%
Pe Ratio-14.708+9%-16.153-17.475+8%9.837-264%29.966-154%76.886-121%
Price Per Share16890.000-10%18550.00020175.000-8%20712.500-10%26252.500-29%30782.501-40%
Price To Free Cash Flow Ratio---0.879-100%-5.5220%6.952-100%-11.5200%
Price To Total Gains Ratio-38.636+9%-42.43319.663-316%-56.218+32%-277.680+554%-750.479+1669%
Quick Ratio---0.402-100%1.288-100%1.313-100%1.176-100%
Return On Assets---0.011-0.020+84%-0.017+57%0.002-763%0.008-235%
Return On Equity---0.019-0.032+68%-0.026+37%-0.002-91%0.012-266%
Total Gains Per Share---437.157-582.110+33%-388.708-11%267.193-264%298.650-246%
Usd Book Value--105886628.400112616064.717-6%127979407.351-17%116022613.186-9%90001332.737+18%
Usd Book Value Change Per Share---0.306-0.407+33%-0.375+23%0.074-512%0.153-300%
Usd Book Value Per Share--10.56611.238-6%12.732-17%11.558-9%8.955+18%
Usd Dividend Per Share----0%0.103-100%0.113-100%0.056-100%
Usd Enterprise Value--47489507.80069710019.288-32%104747921.598-55%143698134.762-67%174498286.057-73%
Usd Eps---0.201-0.358+78%-0.326+62%-0.240+20%-0.041-80%
Usd Free Cash Flow----3283958.2040%-1922905.0860%-2184797.1250%-2538234.8990%
Usd Market Cap118481829.900-10%130126580.500141525809.250-8%145672861.950-11%184398592.315-29%216620977.351-40%
Usd Price Per Share11.823-10%12.98514.123-8%14.499-10%18.377-29%21.548-40%
Usd Profit---2013929.400-3584624.843+78%-3271026.003+62%657660.945-406%1139460.485-277%
Usd Revenue--21114263.10022928158.199-8%24006424.871-12%22368520.509-6%19428366.658+9%
Usd Total Gains Per Share---0.306-0.407+33%-0.272-11%0.187-264%0.209-246%
 EOD+3 -4MRQTTM+14 -16YOY+12 -205Y+7 -2610Y+9 -24

3.3 Fundamental Score

Let's check the fundamental score of Macrogen Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-14.708
Price to Book Ratio (EOD)Between0-11.119
Net Profit Margin (MRQ)Greater than0-0.095
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.804
Debt to Asset Ratio (MRQ)Less than10.438
Debt to Equity Ratio (MRQ)Less than10.789
Return on Equity (MRQ)Greater than0.15-0.019
Return on Assets (MRQ)Greater than0.05-0.011
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Macrogen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.303
Ma 20Greater thanMa 5016,347.500
Ma 50Greater thanMa 10016,945.200
Ma 100Greater thanMa 20017,868.500
OpenGreater thanClose16,900.000
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Macrogen Inc

Macrogen, Inc. provides genetic and genomic analysis research services in South Korea and internationally. It offers next generation sequencing (NGS) services, such as whole genome, exome, targeted, transcriptome, metagenome, epigenome, and single cell multi-omics sequencing, as well as whole genome resequencing; and standard, difficult template, and 16S/18S/26S rRNA and ITS region sequencing services, as well as animal/plant identification, PCR optimization/amplification, pyrosequencing, NGS validation, multi locus sequence typing analysis, sanger sequencing, primer walking, and cloning services. The company also provides fragment analysis services; clinical diagnostic; personal genome analysis; genetic testing services for research purposes, such as messenger RNA, microRNA, single nucleotide polymorphism, comparative genome hybridization, and DNA methylation; oligo and gene synthesis; and clustered regularly interspaced short palindromic repeats design and synthesis material, gRNA synthesis, validated gRNA, and gRNA plasmid services. In addition, it offers genetically engineered mice for use in biological and medical research to identify the functions of human genes; transgenic mouse in which a specific gene has been inserted to study the function of the gene; and GEM-related services, including mass reproduction, microinjection, mouse line recovery, embryo freezing and reproduction, and KO/TG mouse maintenance. Further, the company provides covid-19 test kit under the Axen name, as well as operates smart mobile lab for covid-19 testing. Additionally, it offers iD4U genetic testing services for kinship and personal identification; and myPETGENE genetic testing service for pets. Macrogen, Inc. was founded in 1997 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-12-09 15:37:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Macrogen earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Macrogen to the Biotechnology & Medical Research industry mean.
  • A Net Profit Margin of -9.5% means that ₩-0.10 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Macrogen Inc:

  • The MRQ is -9.5%. The company is making a loss. -1
  • The TTM is -14.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-9.5%TTM-14.7%+5.2%
TTM-14.7%YOY-12.6%-2.2%
TTM-14.7%5Y12.5%-27.2%
5Y12.5%10Y10.7%+1.8%
4.3.1.2. Return on Assets

Shows how efficient Macrogen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Macrogen to the Biotechnology & Medical Research industry mean.
  • -1.1% Return on Assets means that Macrogen generated ₩-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Macrogen Inc:

  • The MRQ is -1.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.1%TTM-2.0%+0.9%
TTM-2.0%YOY-1.7%-0.3%
TTM-2.0%5Y0.2%-2.1%
5Y0.2%10Y0.8%-0.6%
4.3.1.3. Return on Equity

Shows how efficient Macrogen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Macrogen to the Biotechnology & Medical Research industry mean.
  • -1.9% Return on Equity means Macrogen generated ₩-0.02 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Macrogen Inc:

  • The MRQ is -1.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -3.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.9%TTM-3.2%+1.3%
TTM-3.2%YOY-2.6%-0.6%
TTM-3.2%5Y-0.2%-3.1%
5Y-0.2%10Y1.2%-1.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Macrogen Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Macrogen is operating .

  • Measures how much profit Macrogen makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Macrogen to the Biotechnology & Medical Research industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Macrogen Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY0.1%-0.1%
TTM-5Y1.7%-1.7%
5Y1.7%10Y1.3%+0.4%
4.3.2.2. Operating Ratio

Measures how efficient Macrogen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology & Medical Research industry mean).
  • An Operation Ratio of 1.27 means that the operating costs are ₩1.27 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Macrogen Inc:

  • The MRQ is 1.267. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.534. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.267TTM1.534-0.267
TTM1.534YOY1.378+0.156
TTM1.5345Y0.999+0.536
5Y0.99910Y1.012-0.014
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Macrogen Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Macrogen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology & Medical Research industry mean).
  • A Current Ratio of 0.80 means the company has ₩0.80 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Macrogen Inc:

  • The MRQ is 0.804. The company is just not able to pay all its short-term debts. -1
  • The TTM is 1.146. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ0.804TTM1.146-0.343
TTM1.146YOY1.511-0.364
TTM1.1465Y1.443-0.297
5Y1.44310Y1.264+0.179
4.4.3.2. Quick Ratio

Measures if Macrogen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Macrogen to the Biotechnology & Medical Research industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Macrogen Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.402-0.402
TTM0.402YOY1.288-0.886
TTM0.4025Y1.313-0.911
5Y1.31310Y1.176+0.136
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Macrogen Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Macrogen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Macrogen to Biotechnology & Medical Research industry mean.
  • A Debt to Asset Ratio of 0.44 means that Macrogen assets are financed with 43.8% credit (debt) and the remaining percentage (100% - 43.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Macrogen Inc:

  • The MRQ is 0.438. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.389. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.438TTM0.389+0.049
TTM0.389YOY0.351+0.038
TTM0.3895Y0.383+0.007
5Y0.38310Y0.394-0.011
4.5.4.2. Debt to Equity Ratio

Measures if Macrogen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Macrogen to the Biotechnology & Medical Research industry mean.
  • A Debt to Equity ratio of 78.9% means that company has ₩0.79 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Macrogen Inc:

  • The MRQ is 0.789. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.650. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.789TTM0.650+0.139
TTM0.650YOY0.543+0.108
TTM0.6505Y0.654-0.004
5Y0.65410Y0.684-0.030
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Macrogen generates.

  • Above 15 is considered overpriced but always compare Macrogen to the Biotechnology & Medical Research industry mean.
  • A PE ratio of -16.15 means the investor is paying ₩-16.15 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Macrogen Inc:

  • The EOD is -14.708. Based on the earnings, the company is expensive. -2
  • The MRQ is -16.153. Based on the earnings, the company is expensive. -2
  • The TTM is -17.475. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.708MRQ-16.153+1.446
MRQ-16.153TTM-17.475+1.322
TTM-17.475YOY9.837-27.312
TTM-17.4755Y29.966-47.441
5Y29.96610Y76.886-46.920
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Macrogen Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.879-0.879
TTM0.879YOY-5.522+6.401
TTM0.8795Y6.952-6.073
5Y6.95210Y-11.520+18.471
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Macrogen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology & Medical Research industry mean).
  • A PB ratio of 1.23 means the investor is paying ₩1.23 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Macrogen Inc:

  • The EOD is 1.119. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.229. Based on the equity, the company is underpriced. +1
  • The TTM is 1.262. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.119MRQ1.229-0.110
MRQ1.229TTM1.262-0.033
TTM1.262YOY1.146+0.116
TTM1.2625Y1.698-0.436
5Y1.69810Y2.918-1.219
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Net Working Capital  20,814,828-2,220,11018,594,718-2,159,89216,434,826-8,499,0697,935,757-27,567,003-19,631,246



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets269,319,573
Total Liabilities118,052,961
Total Stockholder Equity149,555,141
 As reported
Total Liabilities 118,052,961
Total Stockholder Equity+ 149,555,141
Total Assets = 269,319,573

Assets

Total Assets269,319,573
Total Current Assets80,446,009
Long-term Assets188,873,564
Total Current Assets
Total Current Assets  (as reported)80,446,009
Total Current Assets  (calculated)0
+/- 80,446,009
Long-term Assets
Long-term Assets  (as reported)188,873,564
Long-term Assets  (calculated)0
+/- 188,873,564

Liabilities & Shareholders' Equity

Total Current Liabilities100,077,255
Long-term Liabilities17,975,705
Total Stockholder Equity149,555,141
Total Current Liabilities
Total Current Liabilities  (as reported)100,077,255
Total Current Liabilities  (calculated)0
+/- 100,077,255
Long-term Liabilities
Long-term Liabilities  (as reported)17,975,705
Long-term Liabilities  (calculated)0
+/- 17,975,705
Total Stockholder Equity
Total Stockholder Equity (as reported)149,555,141
Total Stockholder Equity (calculated)0
+/- 149,555,141
Other
Common Stock Shares Outstanding 9,979
Net Invested Capital 149,555,141
Net Working Capital -19,631,246



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
84,417,493
86,600,793
85,961,085
87,712,076
83,537,477
79,996,794
80,714,195
116,178,509
119,570,410
125,279,794
131,148,668
134,311,130
150,442,831
148,266,948
147,621,322
159,523,111
155,846,503
158,236,607
156,098,099
178,707,402
180,875,409
176,800,190
168,030,811
180,415,939
191,823,123
212,251,209
212,184,852
225,531,446
221,151,160
212,789,686
259,330,371
287,789,917
279,300,927
274,515,644
274,219,975
301,176,478
303,451,358
290,216,710
297,150,041
280,125,664
276,540,929
272,651,804
264,179,973
257,818,021
262,578,745
269,319,573
269,319,573262,578,745257,818,021264,179,973272,651,804276,540,929280,125,664297,150,041290,216,710303,451,358301,176,478274,219,975274,515,644279,300,927287,789,917259,330,371212,789,686221,151,160225,531,446212,184,852212,251,209191,823,123180,415,939168,030,811176,800,190180,875,409178,707,402156,098,099158,236,607155,846,503159,523,111147,621,322148,266,948150,442,831134,311,130131,148,668125,279,794119,570,410116,178,50980,714,19579,996,79483,537,47787,712,07685,961,08586,600,79384,417,493
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
95,504,585
94,166,752
125,507,512
128,546,208
124,828,739
116,667,177
133,788,717
140,637,265
114,210,450
116,558,052
105,384,757
96,255,387
89,377,494
130,892,811
96,343,627
93,154,259
94,464,791
94,139,089
100,215,598
99,716,172
89,359,479
85,918,060
90,568,243
85,009,858
77,098,416
67,770,096
74,033,756
75,117,232
80,446,009
80,446,00975,117,23274,033,75667,770,09677,098,41685,009,85890,568,24385,918,06089,359,47999,716,172100,215,59894,139,08994,464,79193,154,25996,343,627130,892,81189,377,49496,255,387105,384,757116,558,052114,210,450140,637,265133,788,717116,667,177124,828,739128,546,208125,507,51294,166,75295,504,58500000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,206,094
16,678,765
43,638,866
41,478,880
22,282,874
21,149,019
32,232,674
17,457,358
14,269,936
14,452,569
16,289,978
10,901,037
14,229,095
48,718,515
28,272,697
19,105,232
26,605,591
37,988,608
38,738,980
0
0
0
37,845,784
29,918,710
29,407,035
18,402,921
23,212,206
18,218,249
0
018,218,24923,212,20618,402,92129,407,03529,918,71037,845,78400038,738,98037,988,60826,605,59119,105,23228,272,69748,718,51514,229,09510,901,03716,289,97814,452,56914,269,93617,457,35832,232,67421,149,01922,282,87441,478,88043,638,86616,678,76518,206,09400000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,931,059
35,000,000
40,000,000
41,391,898
58,664,334
52,363,063
50,079,873
53,132,095
39,054,925
43,294,011
0
0
0
33,616,488
28,844,646
35,817,119
33,245,992
20,247,201
22,100,000
36,519,281
15,362,469
6,979,570
10,100,000
11,141,796
4,258,940
4,247,181
2,100,000
3,699,263
0
03,699,2632,100,0004,247,1814,258,94011,141,79610,100,0006,979,57015,362,46936,519,28122,100,00020,247,20133,245,99235,817,11928,844,64633,616,48800043,294,01139,054,92553,132,09550,079,87352,363,06358,664,33441,391,89840,000,00035,000,00035,931,05900000000000000000
       Net Receivables 
10,923,219
10,639,172
9,929,000
11,397,259
14,008,393
13,648,012
14,548,037
17,731,391
18,254,089
21,080,455
0
24,621,856
22,505,453
19,004,398
19,196,671
20,979,336
21,805,717
22,612,614
24,166,802
24,076,751
25,592,926
25,130,908
21,893,877
22,732,413
28,473,795
24,164,885
27,951,224
32,368,228
34,775,094
30,166,858
30,144,481
25,370,765
24,059,554
20,281,857
20,122,754
23,460,057
27,169,812
21,815,134
25,541,087
21,869,492
23,869,773
23,772,113
25,795,486
26,480,660
29,853,000
0
029,853,00026,480,66025,795,48623,772,11323,869,77321,869,49225,541,08721,815,13427,169,81223,460,05720,122,75420,281,85724,059,55425,370,76530,144,48130,166,85834,775,09432,368,22827,951,22424,164,88528,473,79522,732,41321,893,87725,130,90825,592,92624,076,75124,166,80222,612,61421,805,71720,979,33619,196,67119,004,39822,505,45324,621,856021,080,45518,254,08917,731,39114,548,03713,648,01214,008,39311,397,2599,929,00010,639,17210,923,219
       Other Current Assets 
1,944,982
1,645,205
2,041,504
1,924,324
1,640,408
1,047,836
1,229,443
917,306
1,066,737
1,984,534
28,160,103
1,171,607
3,774,964
4,417,180
3,180,909
2,103,018
2,909,132
3,882,876
3,137,328
1,931,233
3,660,568
3,980,171
4,914,929
2,847,495
420,198
3,930,243
4,488,957
2,400,825
3,843,094
4,522,626
4,912,183
509,169
2,404,880
2,875,775
3,479,003
657,350
4,721,113
5,156,616
6,047,560
250,804
3,642,128
3,657,606
4,262,460
847,021
4,660,389
0
04,660,389847,0214,262,4603,657,6063,642,128250,8046,047,5605,156,6164,721,113657,3503,479,0032,875,7752,404,880509,1694,912,1834,522,6263,843,0942,400,8254,488,9573,930,243420,1982,847,4954,914,9293,980,1713,660,5681,931,2333,137,3283,882,8762,909,1322,103,0183,180,9094,417,1803,774,9641,171,60728,160,1031,984,5341,066,737917,3061,229,4431,047,8361,640,4081,924,3242,041,5041,645,2051,944,982
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
189,557,421
191,531,071
195,553,388
196,409,877
183,784,266
187,461,513
188,873,564
188,873,564187,461,513183,784,266196,409,877195,553,388191,531,071189,557,421000000000000000000000000000000000000000
       Property Plant Equipment 
26,411,468
25,583,865
24,479,976
24,117,385
28,579,028
33,588,329
35,549,165
39,287,230
38,004,974
36,334,408
39,354,560
38,870,542
43,222,051
44,194,071
42,846,639
43,330,602
41,762,186
42,413,771
42,397,765
40,527,171
38,206,226
39,233,718
38,510,178
40,104,246
45,497,210
44,541,879
42,231,637
48,361,830
53,182,851
54,228,683
53,926,836
41,188,860
44,051,915
50,127,955
50,791,308
51,554,713
51,466,059
54,926,343
62,029,796
63,275,348
65,868,813
70,995,299
70,297,769
77,787,598
83,633,051
0
083,633,05177,787,59870,297,76970,995,29965,868,81363,275,34862,029,79654,926,34351,466,05951,554,71350,791,30850,127,95544,051,91541,188,86053,926,83654,228,68353,182,85148,361,83042,231,63744,541,87945,497,21040,104,24638,510,17839,233,71838,206,22640,527,17142,397,76542,413,77141,762,18643,330,60242,846,63944,194,07143,222,05138,870,54239,354,56036,334,40838,004,97439,287,23035,549,16533,588,32928,579,02824,117,38524,479,97625,583,86526,411,468
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,610,310
14,755,726
6,594,796
4,283,927
6,530,538
6,592,692
629,476
608,900
5,581,376
3,355,252
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000003,355,2525,581,376608,900629,4766,592,6926,530,5384,283,9276,594,79614,755,72612,610,31000000000000000000
       Intangible Assets 
28,420
26,360
33,659
83,137
81,496
146,165
146,085
158,618
183,778
432,191
469,957
574,385
584,809
545,700
519,088
486,573
458,409
746,736
756,184
686,885
737,988
706,562
644,076
875,686
914,915
890,924
862,739
8,974,574
9,772,582
10,351,178
9,363,317
1,225,212
1,442,341
1,345,258
1,241,546
1,266,834
1,187,326
1,143,847
1,727,566
2,180,875
1,974,014
2,412,709
2,965,597
2,625,959
2,391,698
0
02,391,6982,625,9592,965,5972,412,7091,974,0142,180,8751,727,5661,143,8471,187,3261,266,8341,241,5461,345,2581,442,3411,225,2129,363,31710,351,1789,772,5828,974,574862,739890,924914,915875,686644,076706,562737,988686,885756,184746,736458,409486,573519,088545,700584,809574,385469,957432,191183,778158,618146,085146,16581,49683,13733,65926,36028,420
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,171
11,664
9,259
1
4,507
0
04,50719,25911,66415,1710000000000000000000000000000000000000000
> Total Liabilities 
31,624,443
30,944,151
28,061,547
27,664,666
19,968,520
16,141,625
16,873,936
49,047,977
51,598,929
54,579,623
60,405,223
56,858,419
71,541,102
67,782,138
69,555,812
75,655,522
74,459,213
74,951,191
73,907,089
83,534,282
54,114,236
51,043,291
51,074,601
61,451,043
64,061,042
81,646,046
82,980,101
112,203,233
110,583,343
105,207,518
153,596,447
89,642,559
88,629,324
83,457,183
82,563,432
100,533,758
99,701,775
92,459,316
95,780,510
100,802,212
100,523,630
98,051,187
88,531,965
96,859,761
106,931,255
118,052,961
118,052,961106,931,25596,859,76188,531,96598,051,187100,523,630100,802,21295,780,51092,459,31699,701,775100,533,75882,563,43283,457,18388,629,32489,642,559153,596,447105,207,518110,583,343112,203,23382,980,10181,646,04664,061,04261,451,04351,074,60151,043,29154,114,23683,534,28273,907,08974,951,19174,459,21375,655,52269,555,81267,782,13871,541,10256,858,41960,405,22354,579,62351,598,92949,047,97716,873,93616,141,62519,968,52027,664,66628,061,54730,944,15131,624,443
   > Total Current Liabilities 
13,735,641
12,310,458
11,644,659
24,902,153
16,952,603
13,268,734
13,451,017
16,868,940
18,720,189
22,073,442
27,504,150
24,763,330
29,520,924
23,345,822
25,103,447
64,200,804
62,549,967
63,423,394
61,654,434
71,161,723
40,911,558
37,787,835
37,319,880
59,438,789
51,980,292
48,214,178
51,209,003
84,604,783
84,651,712
83,514,428
59,275,951
58,045,199
54,484,758
72,738,284
71,931,833
76,546,414
80,014,061
50,489,179
53,250,892
57,572,487
57,184,923
56,283,588
49,175,378
57,598,929
67,181,475
100,077,255
100,077,25567,181,47557,598,92949,175,37856,283,58857,184,92357,572,48753,250,89250,489,17980,014,06176,546,41471,931,83372,738,28454,484,75858,045,19959,275,95183,514,42884,651,71284,604,78351,209,00348,214,17851,980,29259,438,78937,319,88037,787,83540,911,55871,161,72361,654,43463,423,39462,549,96764,200,80425,103,44723,345,82229,520,92424,763,33027,504,15022,073,44218,720,18916,868,94013,451,01713,268,73416,952,60324,902,15311,644,65912,310,45813,735,641
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,373,061
29,625,344
40,077,742
10,753,156
10,978,789
0
0
0
7,804,259
0
9,000,000
9,000,000
9,000,000
9,000,000
9,000,000
9,000,000
9,000,000
9,000,000
9,000,000
9,000,000
9,000,000
9,000,000
9,000,000
9,000,000
9,000,000
0
0
0
0
00009,000,0009,000,0009,000,0009,000,0009,000,0009,000,0009,000,0009,000,0009,000,0009,000,0009,000,0009,000,0009,000,0009,000,0009,000,00007,804,25900010,978,78910,753,15640,077,74229,625,34439,373,06100000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,373,061
29,625,344
40,077,742
10,753,156
10,978,789
0
0
0
7,804,259
0
0
0
0
0
0
0
0
0
0
0
0
0
9,953,180
9,981,440
9,906,970
9,000,000
9,365,064
14,266,844
0
014,266,8449,365,0649,000,0009,906,9709,981,4409,953,18000000000000007,804,25900010,978,78910,753,15640,077,74229,625,34439,373,06100000000000000000
       Accounts payable 
2,143,755
1,945,099
0
1,826,891
1,942,029
1,576,533
1,816,188
4,264,513
6,034,149
5,431,689
0
4,875,163
6,343,488
2,113,562
4,457,463
6,310,339
5,311,746
3,527,879
4,252,494
6,274,661
4,945,131
2,858,207
4,733,332
7,387,258
5,382,897
5,284,689
7,197,241
8,559,567
7,311,449
7,272,861
5,534,393
7,644,602
5,325,088
5,008,720
3,392,770
4,996,528
5,587,192
6,077,914
7,446,285
6,990,019
7,037,357
4,257,330
3,072,732
3,861,763
7,451,077
0
07,451,0773,861,7633,072,7324,257,3307,037,3576,990,0197,446,2856,077,9145,587,1924,996,5283,392,7705,008,7205,325,0887,644,6025,534,3937,272,8617,311,4498,559,5677,197,2415,284,6895,382,8977,387,2584,733,3322,858,2074,945,1316,274,6614,252,4943,527,8795,311,7466,310,3394,457,4632,113,5626,343,4884,875,16305,431,6896,034,1494,264,5131,816,1881,576,5331,942,0291,826,89101,945,0992,143,755
       Other Current Liabilities 
11,591,886
10,365,359
11,644,659
10,312,812
15,010,574
11,185,001
10,584,229
12,604,427
12,409,790
14,730,783
25,473,500
19,545,420
22,684,560
20,836,741
20,388,081
28,158,760
27,575,470
30,188,057
27,651,319
35,120,402
35,849,912
34,929,628
32,586,548
39,500,373
33,455,997
28,492,376
35,493,387
55,829,156
59,153,250
49,938,999
38,991,155
32,423,159
34,594,290
33,468,197
35,530,699
32,957,691
31,786,923
35,411,265
34,061,844
0
29,855,822
27,268,103
147,766
-2
32,951,916
0
032,951,916-2147,76627,268,10329,855,822034,061,84435,411,26531,786,92332,957,69135,530,69933,468,19734,594,29032,423,15938,991,15549,938,99959,153,25055,829,15635,493,38728,492,37633,455,99739,500,37332,586,54834,929,62835,849,91235,120,40227,651,31930,188,05727,575,47028,158,76020,388,08120,836,74122,684,56019,545,42025,473,50014,730,78312,409,79012,604,42710,584,22911,185,00115,010,57410,312,81211,644,65910,365,35911,591,886
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41,594,371
41,401,139
40,224,894
39,356,587
39,260,832
39,749,780
17,975,705
17,975,70539,749,78039,260,83239,356,58740,224,89441,401,13941,594,371000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,599,661
29,089,286
28,312,843
23,793,499
22,716,299
22,468,593
23,542,201
2,395,203
2,364,955
3,183,712
3,678,381
24,473,045
24,201,819
29,800,593
29,487,378
29,026,821
0
0
0
0
000029,026,82129,487,37829,800,59324,201,81924,473,0453,678,3813,183,7122,364,9552,395,20323,542,20122,468,59322,716,29923,793,49928,312,84329,089,28625,599,66100000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-39,373,061
-29,625,344
-40,077,742
-10,753,156
-10,978,789
0
0
0
-7,804,259
0
-9,000,000
-9,000,000
-9,000,000
-9,000,000
-9,000,000
-9,000,000
-9,000,000
-9,000,000
-9,000,000
-9,000,000
-9,000,000
-4,048,668
-2,946,469
-9,000,000
-3,740,374
4,793,569
5,029,100
4,948,219
0
04,948,2195,029,1004,793,569-3,740,374-9,000,000-2,946,469-4,048,668-9,000,000-9,000,000-9,000,000-9,000,000-9,000,000-9,000,000-9,000,000-9,000,000-9,000,000-9,000,000-9,000,0000-7,804,259000-10,978,789-10,753,156-40,077,742-29,625,344-39,373,06100000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0100000000000000000000000000000000000000000000
> Total Stockholder Equity
52,486,766
55,368,763
57,630,696
59,784,964
63,202,775
63,519,882
63,543,266
66,849,192
67,699,142
70,421,726
70,499,584
76,113,114
77,929,994
79,009,069
77,547,716
82,550,821
80,720,068
82,088,504
81,231,101
94,280,116
126,815,429
124,783,194
116,721,610
118,928,899
127,864,584
131,445,533
129,204,751
113,328,214
110,567,817
107,582,167
105,733,924
198,147,358
190,671,604
191,058,462
191,656,543
200,642,719
203,749,584
197,757,394
201,369,531
179,323,452
176,017,299
174,600,616
174,216,635
159,190,685
153,748,738
149,555,141
149,555,141153,748,738159,190,685174,216,635174,600,616176,017,299179,323,452201,369,531197,757,394203,749,584200,642,719191,656,543191,058,462190,671,604198,147,358105,733,924107,582,167110,567,817113,328,214129,204,751131,445,533127,864,584118,928,899116,721,610124,783,194126,815,42994,280,11681,231,10182,088,50480,720,06882,550,82177,547,71679,009,06977,929,99476,113,11470,499,58470,421,72667,699,14266,849,19263,543,26663,519,88263,202,77559,784,96457,630,69655,368,76352,486,766
   Common Stock
2,842,227
2,867,966
2,907,565
2,907,565
2,947,169
2,947,169
2,947,168
2,947,169
4,423,368
4,447,129
4,456,040
4,457,540
4,458,790
4,458,790
4,458,790
4,485,521
4,714,224
4,715,724
4,715,724
4,715,724
5,297,727
5,302,727
5,302,727
5,302,727
5,302,727
5,302,727
5,302,727
5,302,727
5,302,727
5,305,827
5,305,827
5,315,827
5,326,314
5,357,776
5,357,776
5,420,700
5,420,700
5,420,700
5,420,700
5,420,700
5,420,700
5,420,700
0
0
0
0
00005,420,7005,420,7005,420,7005,420,7005,420,7005,420,7005,420,7005,357,7765,357,7765,326,3145,315,8275,305,8275,305,8275,302,7275,302,7275,302,7275,302,7275,302,7275,302,7275,302,7275,302,7275,297,7274,715,7244,715,7244,715,7244,714,2244,485,5214,458,7904,458,7904,458,7904,457,5404,456,0404,447,1294,423,3682,947,1692,947,1682,947,1692,947,1692,907,5652,907,5652,867,9662,842,227
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
88,017,446
92,823,805
93,078,178
88,227,023
88,227,023
94,323,598
89,407,838
91,012,922
91,012,922
94,287,050
94,179,142
94,179,142
94,179,142
94,287,050
94,179,142
94,179,142
0
0
0
0
000094,179,14294,179,14294,287,05094,179,14294,179,14294,179,14294,287,05091,012,92291,012,92289,407,83894,323,59888,227,02388,227,02393,078,17892,823,80588,017,44600000000000000000000000000
   Treasury Stock0000000000-29,006,698000-26,494,14400-24,336,665-22,844,3310000-19,429,459-12,229,867-10,295,612-10,295,612-10,295,612-10,295,612-10,295,612-3,369,144-3,369,144-3,369,144-3,369,144-3,369,144-2,866,728-71,956-71,956-627,575-204,546-204,546-204,546-19-20-19-20
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,547,782
3,084,170
4,049,469
4,049,504
4,465,465
4,704,497
4,455,979
4,388,846
4,414,201
-15,083,437
6,010,924
5,469,719
6,189,618
7,208,382
5,447,672
5,956,306
6,268,239
6,859,242
6,769,395
6,933,326
5,823,251
7,643,944
-102,528
-19,654,315
-18,525,559
0
0
0
0
0000-18,525,559-19,654,315-102,5287,643,9445,823,2516,933,3266,769,3956,859,2426,268,2395,956,3065,447,6727,208,3826,189,6185,469,7196,010,924-15,083,4374,414,2014,388,8464,455,9794,704,4974,465,4654,049,5044,049,4693,084,1703,547,78200000000000000000



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue132,803,132
Cost of Revenue-83,563,455
Gross Profit49,239,67749,239,677
 
Operating Income (+$)
Gross Profit49,239,677
Operating Expense-133,217,473
Operating Income-414,341-83,977,796
 
Operating Expense (+$)
Research Development4,545,941
Selling General Administrative10,583,399
Selling And Marketing Expenses0
Operating Expense133,217,47315,129,340
 
Net Interest Income (+$)
Interest Income895,004
Interest Expense-983,622
Other Finance Cost-0
Net Interest Income-88,618
 
Pretax Income (+$)
Operating Income-414,341
Net Interest Income-88,618
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-20,233,234-414,341
EBIT - interestExpense = -983,622
-16,813,947
-15,830,325
Interest Expense983,622
Earnings Before Interest and Taxes (EBIT)0-19,249,612
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-20,233,234
Tax Provision--3,482,698
Net Income From Continuing Ops-16,750,535-16,750,535
Net Income-16,813,947
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net088,618
 

Technical Analysis of Macrogen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Macrogen. The general trend of Macrogen is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Macrogen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Macrogen Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 18,290 < 18,500 < 18,750.

The bearish price targets are: 14,700.

Tweet this
Macrogen Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Macrogen Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Macrogen Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Macrogen Inc. The current macd is -32.20939272.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Macrogen price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Macrogen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Macrogen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Macrogen Inc Daily Moving Average Convergence/Divergence (MACD) ChartMacrogen Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Macrogen Inc. The current adx is 17.46.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Macrogen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Macrogen Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Macrogen Inc. The current sar is 17,509.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Macrogen Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Macrogen Inc. The current rsi is 54.30. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Macrogen Inc Daily Relative Strength Index (RSI) ChartMacrogen Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Macrogen Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Macrogen price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Macrogen Inc Daily Stochastic Oscillator ChartMacrogen Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Macrogen Inc. The current cci is 67.37.

Macrogen Inc Daily Commodity Channel Index (CCI) ChartMacrogen Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Macrogen Inc. The current cmo is 17.01.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Macrogen Inc Daily Chande Momentum Oscillator (CMO) ChartMacrogen Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Macrogen Inc. The current willr is -38.99721448.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Macrogen is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Macrogen Inc Daily Williams %R ChartMacrogen Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Macrogen Inc.

Macrogen Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Macrogen Inc. The current atr is 653.50.

Macrogen Inc Daily Average True Range (ATR) ChartMacrogen Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Macrogen Inc. The current obv is 16,399,420.

Macrogen Inc Daily On-Balance Volume (OBV) ChartMacrogen Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Macrogen Inc. The current mfi is 55.25.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Macrogen Inc Daily Money Flow Index (MFI) ChartMacrogen Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Macrogen Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-10STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Macrogen Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Macrogen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.303
Ma 20Greater thanMa 5016,347.500
Ma 50Greater thanMa 10016,945.200
Ma 100Greater thanMa 20017,868.500
OpenGreater thanClose16,900.000
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Macrogen with someone you think should read this too:
  • Are you bullish or bearish on Macrogen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Macrogen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Macrogen Inc

I send you an email if I find something interesting about Macrogen Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Macrogen Inc.

Receive notifications about Macrogen Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.